Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-7655 + imipenem/cilastatin versus imipenem/cilastatin in complicated urinary tract infection
2011-005707-32Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of relebactam, imipenem, cilastatin in complicated urinary tract infection (cUTI), acute pyelonephritis, sponsored by Merck & Co.. Started Mar 2012; status: terminated.
02
Drugs
relebactamimipenemcilastatin
03
Conditions
complicated urinary tract infection (cUTI)acute pyelonephritis
Beyond the preview
Go deeper on 2011-005707-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005707-32.